Wells Fargo
FBLG icon

Wells Fargo’s FibroBiologics FBLG Stock Holding History

Wells Fargo’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13 Hold
10
– – ﹤0.01% 6905
2025
Q4 		$45 Hold
10
– – ﹤0.01% 6541
2025
Q3 		$109 Sell
10
-26
-72% -$311 ﹤0.01% 6377
2025
Q2 		$451 Sell
36
-627
-95% -$11.3K ﹤0.01% 6382
2025
Q1 		$11.9K Buy
663
+14
+2% +$400 ﹤0.01% 5855
2024
Q4 		$26K Buy
649
+211
+48% +$11.3K ﹤0.01% 5693
2024
Q3 		$27.1K Buy
438
+21
+5% +$1.4K ﹤0.01% 5555
2024
Q2 		$41.7K Buy
417
+407
+4,070% +$77.6K ﹤0.01% 5360
2024
Q1 		$2.16K Buy
+10
New +$2.4K ﹤0.01% 6022

Other funds holding FBLG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.25B AUM 14.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

Wells Fargo's FBLG Position: Q1 2026 in Review

Wells Fargo held its FibroBiologics (FBLG) position steady in Q1 2026 at 10 shares worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #6905.

Wells Fargo first reported a position in FBLG in Q1 2024 and has held it in 9 quarters since. The position peaked at $41.7K in Q2 2024. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

  • Wells Fargo held 10 shares of FibroBiologics worth $13 as of Q1 2026.
  • Wells Fargo left its FibroBiologics share count unchanged in Q1 2026.
  • FibroBiologics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6905 holding.
  • Wells Fargo first reported a position in FibroBiologics in Q1 2024 and has held it in 9 quarters since.
  • Wells Fargo's FibroBiologics position peaked at $41.7K in Q2 2024.
  • 17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.